1110 Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
1110 Stock 12 Month Forecast
Average Price Target
€7.01
▲(11590.13% Upside)
| Highest Price Target€8.77 | Average Price Target€7.01 | Lowest Price Target€5.26 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Maxim Group
€5.26
Buy
8667.60%
Upside
Initiated
06/04/26
H.C. Wainwright
€8.77
Buy
14512.67%
Upside
Reiterated
05/20/26
Ascendiant
€10.52
Buy
17435.20%
Upside
Reiterated
04/07/26
We are adjusting our 2026 estimates for revenue to $1.5 million, from $1.8 million, and for EPS to $(2.16) from $(2.13). Focus on silicon nitride commercialization: SINTX is focused on developing silicon nitride products for medical and non-medical products in collaboration with medical/non-medical products manufacturers. SINTX believes that silicon nitride has a superb combination of properties that make it ideally suited for many medical applications. The company is now focusing and aiming for wide commercial opportunities across bio-medical industries for silicon nitride. In June 2025, SINTX acquired the surgical business assets of SiNAPTIC Holdings, a privately held company focused on silicon nitride ceramic manufacturing and innovation. This includes (6) differentiated foot and ankle implant systems.
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Maxim Group
€5.26
Buy
8667.60%
Upside
Initiated
06/04/26
H.C. Wainwright
€8.77
Buy
14512.67%
Upside
Reiterated
05/20/26
Ascendiant
€10.52
Buy
17435.20%
Upside
Reiterated
04/07/26
We are adjusting our 2026 estimates for revenue to $1.5 million, from $1.8 million, and for EPS to $(2.16) from $(2.13). Focus on silicon nitride commercialization: SINTX is focused on developing silicon nitride products for medical and non-medical products in collaboration with medical/non-medical products manufacturers. SINTX believes that silicon nitride has a superb combination of properties that make it ideally suited for many medical applications. The company is now focusing and aiming for wide commercial opportunities across bio-medical industries for silicon nitride. In June 2025, SINTX acquired the surgical business assets of SiNAPTIC Holdings, a privately held company focused on silicon nitride ceramic manufacturing and innovation. This includes (6) differentiated foot and ankle implant systems.
Best Analysts Covering Sintx Technologies
3 Months
Success Rate
2/12 ratings generated profit
Average Return
-31.22%
Copying Edward Woo's trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -31.22% per trade.
1 Year
Success Rate
1/12 ratings generated profit
Average Return
-61.73%
Copying Edward Woo's trades and holding each position for 1 Year would result in 8.33% of your transactions generating a profit, with an average return of -61.73% per trade.
2 Years
Success Rate
1/12 ratings generated profit
Average Return
-68.53%
Copying Edward Woo's trades and holding each position for 2 Years would result in 8.33% of your transactions generating a profit, with an average return of -68.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
1110 Analyst Recommendation Trends
Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
2
3
4
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
2
3
4
2
Each month's total comprises the sum of three months' worth of ratings.
1110 Financial Forecast
1110 Stock Forecast FAQ
What is DE:1110’s average 12-month price target, according to analysts?
Based on analyst ratings, Sintx Technologies Inc’s 12-month average price target is 7.01.
What is DE:1110’s upside potential, based on the analysts’ average price target?
Sintx Technologies Inc has 11590.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sintx Technologies Inc a Buy, Sell or Hold?
Sintx Technologies Inc has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sintx Technologies Inc’s share price target?
The average share price target for Sintx Technologies Inc is 7.01. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €8.77 ,and the lowest forecast is €5.26. The average share price target represents 11590.13% Increase from the current price of <€0.1.
The highest analyst share price target is €8.77 ,and the lowest forecast is €5.26. The average share price target represents 11590.13% Increase from the current price of <€0.1.
What do analysts say about Sintx Technologies Inc?
Sintx Technologies Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Sintx Technologies Inc?
To buy shares of DE:1110, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.